Brown Advisory’s Pulse Biosciences PLSE Stock Holding History

Brown Advisory’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,500	Closed	-$248K	–	1256
2017 Q4	$248K	Buy	+10,500	New	+$248K	﹤0.01%	1099

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Brown Advisory's PLSE Position: Q1 2018 in Review

Brown Advisory sold out of Pulse Biosciences (PLSE) in Q1 2018, closing a stake of 10,500 shares — an estimated $248K sold.

Brown Advisory first reported a position in PLSE in Q4 2017 and held it in 1 quarter. The position peaked at $248K in Q4 2017. 47 funds tracked by Wall St. Rank hold PLSE as of Q1 2018.

Brown Advisory reported no remaining Pulse Biosciences position as of Q1 2018 after selling out during the quarter.
Brown Advisory sold 10,500 Pulse Biosciences shares in Q1 2018, an estimated $248K.
Brown Advisory first reported a position in Pulse Biosciences in Q4 2017 and held it in 1 quarter.
Brown Advisory's Pulse Biosciences position peaked at $248K in Q4 2017.
47 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2018.

Based on Brown Advisory's 13F filing for Q1 2018, filed 14 May 2018.